{
  "Variants Include": [
    {
      "Gene": "MT-ATP6",
      "variants": [
        {
          "HGVS": "NM_012584.3:c.792C>T",
          "cDNA Change": {
            "transcript": "NM_012584.3",
            "ref": "C",
            "alt": "T",
            "position": "792"
          },
          "Protein Change": {
            "ref": "Ala",
            "alt": "Val",
            "position": "264"
          },
          "Description in input context": "c.792C>T (p.Ala264Val)"
        }
      ]
    },
    {
      "Gene": "MT-ATP8",
      "variants": [
        {
          "HGVS": "NM_012587.3:c.349C>T",
          "cDNA Change": {
            "transcript": "NM_012587.3",
            "ref": "C",
            "alt": "T",
            "position": "349"
          },
          "Protein Change": {
            "ref": "Ala",
            "alt": "Val",
            "position": "116"
          },
          "Description in input context": "c.349C>T (p.Ala116Val)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)",
    "MONDO": "MONDO:0012346"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "HeLa cells",
        "Material Name": "HeLa-mito cell line",
        "Description": "The experiment was conducted using a HeLa cell line that expresses mitochondrial proteins."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_012584.3:c.792C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The expression of the Ala264Val variant in MT-ATP6 protein was reduced by 50%."
        },
        {
          "Variant": "NM_012587.3:c.349C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The expression of the Ala116Val variant in MT-ATP8 protein was reduced by 30%."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA for each gene was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}